keyword
https://read.qxmd.com/read/38718300/clinical-practice-patterns-in-sickle-cell-disease-treatment-disease-modifying-and-potentially-curative-therapies
#1
JOURNAL ARTICLE
Luisanna M Sánchez, Kerry Morrone, Melissa Frei-Jones, Titilope A Fasipe
Therapeutic options for sickle cell disease (SCD) have increased recently as well as the development of updated national guidelines. It is not known how these options are being offered or to what degree guidelines are incorporated into clinical practice. This study aimed to describe practice patterns for pediatric hematologists regarding the use of disease-modifying and potentially curative therapies for SCD. A 9-section, cross-sectional electronic survey was disseminated during a 3-month period via SurveyMonkey, to members of the American Society of Pediatric Hematology/Oncology Hemoglobinopathy Special Interest Group (ASPHO HSIG)...
May 7, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38718139/2024-aha-acc-amssm-hrs-paces-scmr-guideline-for-the-management-of-hypertrophic-cardiomyopathy-a-report-of-the-american-heart-association-american-college-of-cardiology-joint-committee-on-clinical-practice-guidelines
#2
REVIEW
Steve R Ommen, Carolyn Y Ho, Irfan M Asif, Seshadri Balaji, Michael A Burke, Sharlene M Day, Joseph A Dearani, Kelly C Epps, Lauren Evanovich, Victor A Ferrari, José A Joglar, Sadiya S Khan, Jeffrey J Kim, Michelle M Kittleson, Chayakrit Krittanawong, Matthew W Martinez, Seema Mital, Srihari S Naidu, Sara Saberi, Christopher Semsarian, Sabrina Times, Cynthia Burstein Waldman
AIM: The "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy" provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy. METHODS: A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline...
May 8, 2024: Circulation
https://read.qxmd.com/read/38717943/advances-in-pharmacotherapies-for-cytomegalovirus-infection-what-is-the-current-state-of-play
#3
REVIEW
Lea M Monday, Vishakh Keri, Pranatharthi H Chandrasekar
INTRODUCTION: Cytomegalovirus (CMV) remains a serious opportunistic infection in hematopoietic cell transplant (HCT) and solid-organ transplant (SOT) recipients. Traditional anti-CMV drugs are limited by toxicities and the development of resistance. Letermovir and maribavir are newly approved antivirals for the prevention and treatment of CMV. AREAS COVERED: Prior reviews have discussed use of letermovir for prevention of CMV after HCT and maribavir for resistant or refractory (R/R) CMV post HCT or SOT...
May 8, 2024: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/38717637/a-new-perspective-on-therapies-involving-b-cell-depletion-in-autoimmune-diseases
#4
REVIEW
Sulieman Ibraheem Shelash Al-Hawary, Saade Abdalkareem Jasim, Ahmed Hjazi, Himayat Ullah, Pooja Bansal, Mahamedha Deorari, I B Sapaev, Ahmed Ali Ami, Karrar Hatif Mohmmed, Munther Kadhim Abosaoda
It has been rediscovered in the last fifteen years that B-cells play an active role in autoimmune etiology rather than just being spectators. The clinical success of B-cell depletion therapies (BCDTs) has contributed to this. BCDTs, including those that target CD20, CD19, and BAFF, were first developed to eradicate malignant B-cells. These days, they treat autoimmune conditions like multiple sclerosis and systemic lupus erythematosus. Particular surprises have resulted from the use of BCDTs in autoimmune diseases...
May 8, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38717044/evaluating-the-cost-effectiveness-of-voclosporin-for-the-treatment-of-lupus-nephritis-in-the-united-states
#5
JOURNAL ARTICLE
Lisa Kennedy, Ernie Lee, Ronald Flauto, Victoria Atencio, Vanessa Birardi
BACKGROUND: Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus; up to 30% of patients with LN will develop end-stage kidney disease (ESKD). One of the main treatment goals for LN is preservation of kidney function, with early decreases in proteinuria associated with improved long-term outcomes. Voclosporin, a second-generation calcineurin inhibitor, was approved in the United States in 2021 for the treatment of active LN combined with background immunosuppression...
May 8, 2024: Journal of Managed Care & Specialty Pharmacy
https://read.qxmd.com/read/38716591/-chinese-expert-consensus-on-the-diagnosis-and-management-of-primary-mediastinal-large-b-cell-lymphoma-2024
#6
JOURNAL ARTICLE
(no author information available yet)
Primary mediastinal large B-cell lymphoma (PMBL) is an aggressive B-cell lymphoma that is thought to arise from thymic (medullary) B cells and has unique clinicopathologic and molecular features. In recent years, the understanding of the pathogenesis and treatment of PMBL has been updated to varying degrees, particularly in the area of new drug therapy. In order to improve the diagnosis and treatment of PMBL in China, the Lymphocyte Disease Group of the Chinese Medical Association (CMA) and the Anti-Lymphoma Alliance of the Chinese Society of Clinical Oncology (CSCO) commissioned a group of experts to formulate this consensus...
March 14, 2024: Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi
https://read.qxmd.com/read/38716224/histopathological-insight-of-a-case-of-adenoid-ameloblastoma-a-rare-odontogenic-tumor
#7
Shashi Keshwar, Toniya Raut, Neetu Jain, Ashish Shrestha, Mehul Rajesh Jaisani
Adenoid ameloblastoma with dentinoid had been perceived as a rare odontogenic tumor with bridging histopathological features between ameloblastoma and adenomatoid odontogenic tumor. Due to the mixture of histopathological features of two separate and well-recognized entities, adenoid ameloblastoma was also regarded as a hybrid lesion. The diversity in the histopathological presentation among the cases has disaccorded the nature, behaviour, and prognosis of this pathology. Despite the literature acknowledging the histopathological diversity, categorizing all these variations into one and addressing them as a single entity was lagging till the 5th edition of the odontogenic tumor classification by the WHO was forwarded...
2024: Case Reports in Dentistry
https://read.qxmd.com/read/38716213/lower-fib-4-threshold-in-patients-with-diabetes-improves-diagnostic-accuracy-of-the-test-in-a-hispanic-population
#8
JOURNAL ARTICLE
Jasleen Singh, Brittney Ibrahim, Nicholas J Jackson, Haydar Khalil, Julia Valenzuela, Beshoy Yanny, Sammy Saab
BACKGROUND: Non-invasive tests (NITs) can be used to estimate the severity of fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) but their diagnostic accuracy is variable. Hispanic patients are at increased risk of NAFLD and diabetes. We evaluate the diagnostic performance of the fibrosis index based on 4 factors (FIB-4) in a population of Hispanic patients who underwent vibration-controlled transient elastography (VCTE). METHODS: A total of 1,524 patients underwent VCTE at University of California, Los Angeles from July 18, 2019 to June 7, 2022...
2024: Translational Gastroenterology and Hepatology
https://read.qxmd.com/read/38716193/updates-on-traditional-methods-for-combating-malaria-and-emerging-wolbachia-based-interventions
#9
REVIEW
Iqra Mushtaq, Muhammad Sajjad Sarwar, Ammara Chaudhry, Syed Ali Haider Shah, Muhammad Mubeen Ahmad
The escalating challenge of malaria control necessitates innovative approaches that extend beyond traditional control strategies. This review explores the incorporation of traditional vector control techniques with emerging Wolbachia -based interventions. Wolbachia , a naturally occurring bacteria, offers a novel approach for combatting vector-borne diseases, including malaria, by reducing the mosquitoes' ability to transmit these diseases. The study explores the rationale for this integration, presenting various case studies and pilot projects that have exhibited significant success...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38715762/non-fungible-tokens-for-organoids-decentralized-biobanking-to-empower-patients-in-biospecimen-research
#10
William Sanchez, Larue Linder, Robert C Miller, Amelia Hood, Marielle S Gross
INTRODUCTION: Scientists use donated biospecimens to create organoids, which are miniature copies of patient tumors that are revolutionizing precision medicine and drug discovery. However, biobanking platforms remove donor identifiers to protect privacy, precluding patients from benefiting from their contributions or sharing information that may be relevant to research outcomes. Decentralized biobanking (de-bi) leverages blockchain technology to empower patient engagement in biospecimen research...
2024: Blockchain in healthcare today
https://read.qxmd.com/read/38715356/implementing-a-safe-sleep-shelter-and-baby-bundle-kit-distribution-program
#11
JOURNAL ARTICLE
Trina C Salm Ward, Terri J Miller
The Georgia Department of Public Health developed the Safe Sleep Shelter Program to expand Georgia Safe to Sleep campaign efforts. The program focused on engaging with housing support agencies, homeless shelters, and domestic violence shelters. The program offered a menu of resources that agencies could choose from, including portable cribs for agency use and distribution to families, safe sleep education for staff, assistance with creating/updating agency safe sleep policies, and Baby Bundle Safe Sleep kits with education and resources for families...
May 7, 2024: Health Promotion Practice
https://read.qxmd.com/read/38714590/the-unification-of-evolutionary-dynamics-through-the-bayesian-decay-factor-in-a-game-on-a-graph
#12
JOURNAL ARTICLE
Arnaud Zlatko Dragicevic
We unify evolutionary dynamics on graphs in strategic uncertainty through a decaying Bayesian update. Our analysis focuses on the Price theorem of selection, which governs replicator(-mutator) dynamics, based on a stratified interaction mechanism and a composite strategy update rule. Our findings suggest that the replication of a certain mutation in a strategy, leading to a shift from competition to cooperation in a well-mixed population, is equivalent to the replication of a strategy in a Bayesian-structured population without any mutation...
May 7, 2024: Bulletin of Mathematical Biology
https://read.qxmd.com/read/38714503/editorial-updates-from-the-new-editors-in-chief
#13
EDITORIAL
Fuschia Sirois, Andrew R Thompson
No abstract text is available yet for this article.
May 7, 2024: British Journal of Health Psychology
https://read.qxmd.com/read/38714379/european-association-of-urology-guidelines-on-urological-infections-summary-of-the-2024-guidelines
#14
REVIEW
Jennifer Kranz, Riccardo Bartoletti, Franck Bruyère, Tommaso Cai, Suzanne Geerlings, Bela Köves, Sören Schubert, Adrian Pilatz, Rajan Veeratterapillay, Florian M E Wagenlehner, Kathrin Bausch, Wout Devlies, József Horváth, Lorenz Leitner, Guglielmo Mantica, Tunde Mezei, Emma J Smith, Gernot Bonkat
BACKGROUND AND OBJECTIVE: Urological infections significantly impact the wellbeing and quality of life of individuals owing to their widespread occurrence and diverse clinical manifestations. The objective of the guidelines panel was to provide evidence-based guidance on the diagnosis, treatment, and prevention of urinary tract infections (UTIs) and male accessory-gland infections, while addressing crucial public health aspects related to infection control and antimicrobial stewardship...
May 6, 2024: European Urology
https://read.qxmd.com/read/38714286/bringing-platform-trials-closer-to-reality-by-enabling-with-digital-research-environment-dre-connectivity
#15
JOURNAL ARTICLE
Jeffrey S Barrett, Kara Lasater, Scott Russell, Susan McCune, Timothy M Miller, David Sibbald
Platform trials are generally regarded as an innovative approach to address clinical valuation of early stage candidates, regardless of modality as the evidence evolves. As a type of randomized clinical trial (RCT) design construct in which multiple interventions are evaluated concurrently against a common control group allowing new interventions to be added and the control group to be updated throughout the trial, they provide a dynamic and efficient mechanism to compare and potentially discriminate new treatment candidates...
May 5, 2024: Contemporary Clinical Trials
https://read.qxmd.com/read/38713405/an-update-on-tests-used-for-intraoperative-monitoring-of-cognition-during-awake-craniotomy
#16
REVIEW
Beleke de Zwart, Carla Ruis
PURPOSE: Mapping higher-order cognitive functions during awake brain surgery is important for cognitive preservation which is related to postoperative quality of life. A systematic review from 2018 about neuropsychological tests used during awake craniotomy made clear that until 2017 language was most often monitored and that the other cognitive domains were underexposed (Ruis, J Clin Exp Neuropsychol 40(10):1081-1104, 218). The field of awake craniotomy and cognitive monitoring is however developing rapidly...
May 7, 2024: Acta Neurochirurgica
https://read.qxmd.com/read/38713046/-new-clinical-guidelines-for-copd-a-paradigm-shift-a-review
#17
REVIEW
S N Avdeev, I V Leshchenko, Z R Aisanov, V V Arkhipov, A S Belevskiy, S I Ovcharenko, A V Emelyanov, A I Sinopalnikov, E I Shmelev, A G Chuchalin
Chronic obstructive pulmonary disease is now one of the most common noncommunicable diseases and the main causes of morbidity, disability and mortality in the world. In recent years, new approaches to epidemiology, diagnosis, classification (categorization), evaluation of phenotypes, as well as characterization and assessment of the severity of сhronic obstructive pulmonary disease exacerbations have emerged. Modern approaches to starting and subsequent drug therapy have changed significantly. This is largely due to the results of recently conducted major clinical trials, demonstrated high efficacy of triple fixed combinations, including inhaled glucocorticosteroids, long-acting beta-agonists and long-acting anticholinergic drugs...
April 16, 2024: Terapevticheskiĭ Arkhiv
https://read.qxmd.com/read/38712916/the-role-of-telehealth-in-the-delivery-of-oral-and-maxillofacial-surgery-services-at-a-level-6-hospital-in-new-south-wales-australia-during-covid-19-the-john-hunter-hospital-experience-a-commentary-review-and-cautionary-tale-for-the-future
#18
JOURNAL ARTICLE
Annabelle Welham, Eileen Tan-Gore, Rebekah Taylor
PURPOSE OF REVIEW: The objective of this article is to understand the uptake in use of Telehealth services during the COVID-19 pandemic as a way to provide compelling impetus for further research and promotion of Telehealth in general. A data review of Outpatient Department data from 2020 to 2023, as compiled by the Surgical Outcomes improvement Unit. RECENT FINDINGS: Telehealth was widely adopted during the COVID-19 pandemic for clinicians to provide healthcare to patients whilst adhering to strict lockdown guidelines aimed at limiting exposure and spread of the respiratory virus...
May 7, 2024: Current Opinion in Otolaryngology & Head and Neck Surgery
https://read.qxmd.com/read/38712714/systemic-antibiotics-for-symptomatic-apical-periodontitis-and-acute-apical-abscess-in-adults
#19
REVIEW
Anwen L Cope, Nick Francis, Fiona Wood, Wendy Thompson, Ivor G Chestnutt
BACKGROUND: Dental pain can have a detrimental effect on quality of life. Symptomatic apical periodontitis and acute apical abscess are common causes of dental pain and arise from an inflamed or necrotic dental pulp, or infection of the pulpless root canal system. Clinical guidelines recommend that the first-line treatment for these conditions should be removal of the source of inflammation or infection by local operative measures, and that systemic antibiotics are currently only recommended for situations where there is evidence of spreading infection (cellulitis, lymph node involvement, diffuse swelling) or systemic involvement (fever, malaise)...
May 7, 2024: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/38712709/collaborative-care-approaches-for-people-with-severe-mental-illness
#20
REVIEW
Siobhan Reilly, Charley Hobson-Merrett, Bliss Gibbons, Ben Jones, Debra Richards, Humera Plappert, John Gibson, Maria Green, Linda Gask, Peter J Huxley, Benjamin G Druss, Claire L Planner
BACKGROUND: Collaborative care for severe mental illness (SMI) is a community-based intervention that promotes interdisciplinary working across primary and secondary care. Collaborative care interventions aim to improve the physical and/or mental health care of individuals with SMI. This is an update of a 2013 Cochrane review, based on new searches of the literature, which includes an additional seven studies. OBJECTIVES: To assess the effectiveness of collaborative care approaches in comparison with standard care (or other non-collaborative care interventions) for people with diagnoses of SMI who are living in the community...
May 7, 2024: Cochrane Database of Systematic Reviews
keyword
keyword
88406
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.